By Buy This GLP Editorial Team
TeleDocs360 review
Thirty-day billing
A disclosed upper-dose surcharge and a partly retained evaluation fee are the main buying considerations.
What TeleDocs360 charges, and what it bills
One row per molecule and delivery route. Where the two figures differ, the struck number is what TeleDocs360 leads with and the figure under it is what a buyer cannot get below. Both are published by the seller; neither is a walked checkout.
| Product | Per month | 6 months | As the dose rises |
|---|---|---|---|
| Semaglutide, injectionRises as the dose rises, per the seller. | $299 | $1,794 | Rises as the dose rises, per the seller. |
| Tirzepatide, injectionRises as the dose rises, per the seller. | $399 | $2,394 | Rises as the dose rises, per the seller. |
The 6-month column is the billed monthly figure multiplied by 6. It is arithmetic on published prices, not a forecast of a bill: a real six months also carries dose changes, labs and shipping, and those are covered below where TeleDocs360 states them.
The bottom line
TeleDocs360 lists semaglutide for $299 per 30-day cycle. The tirzepatide starting tier costs $399, with $549 charged for the two highest listed doses. Compare the dose you expect to receive, not just the entry amount.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at TeleDocs360
- Prepay
- The public plans renew on a 30-day schedule. An introductory discount was excluded from this comparison.
- Cancellation
- Request cancellation before a renewal or medication order is processed. Confirm how the physician-fee policy applies to your order.
Pricing transparency
How TeleDocs360 publishes its prices
A $99 evaluation charge sits inside the program price. The detailed policy retains it after the medical review even if the selected treatment is declined. One semaglutide statement still offers a full refund, creating a discrepancy worth resolving in writing.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- From
- $299/mo
- Dose published
- Yes
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
The seller
What TeleDocs360 is
This online service sells clinician-reviewed weight-management programs. It manages the administrative purchase process while medical professionals decide whether medication is appropriate. These injection offers concern compounded products.
How it works
The customer chooses a program and pays before the evaluation is complete. Access to the clinical system follows. Refills require review, and treatment approval is not assured by payment.
Branded or compounded
The marketed injections use compounded semaglutide or tirzepatide. They should not be treated as FDA-approved brand pens. Supplies and ordinary delivery are included in the advertised program.
Where the money holds, and where it moves
Predictable
- Thirty-day charge interval is stated
- Upper-dose amount is visible before enrollment
- Clinical review is included in the package
Moves, or is not stated
- Higher tirzepatide doses cost more
- Evaluation can leave a nonrefundable balance
- Refund messaging needs clarification
Who this is worth it for
A cash customer budgeting for a disclosed recurring charge and a known dose tier.
Who should price elsewhere
Someone requiring insurance billing or guaranteed reimbursement of the entire payment if declined.
The molecules
What TeleDocs360 prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide 50 mg and the Injection: A 30-Study Systematic Review
A 2026 review of 30 studies put the 50 mg tablet at −15.1% in OASIS 1 and the 2.4 mg injection at −14.9% in STEP 1, two separate trials. Bioavailability is about 1% for the tablet, against 89% injected.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
The premium buys measured extra weight loss: 20.2 percent against 13.7 percent in a head-to-head trial. On heart attacks and strokes it buys nothing measurable.
Priced against
Sellers to price beside TeleDocs360
RoBuyers who want brand-name drugs and help with insurance paperwork
See Ro →
Mochi HealthBuyers who want a dose-by-dose price list and will add the membership
See Mochi Health →
Henry MedsA buyer who wants to know how many milligrams a monthly rate buys before starting
See Henry Meds →
More GLP-1 sellers by price priced end to end: MediRXMedLeanRxMedroMedsol RXMEDViMetaboost Rx
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Which tirzepatide doses have the higher charge?
Does the price include the consultation?
Is TeleDocs360 expensive compared with other GLP-1 sellers by price providers?
Or go back to the price desk and compare TeleDocs360 against every seller on it.